Pierre Fenaux, et al.. Increased frequency of hematopoietic malignancies in relatives of patients with lymphoid neoplasms: a French case-control study.Abstract Lymphoid neoplasms (LN), including non-Hodgkin's lymphoma (NHL), Hodgkin's lymphoma (HL), lymphoproliferative syndrome (LPS) and multiple myeloma (MM), are among the most frequent cancers (approximately 17,000 new cases per year in France), after those related to smoking. LN were investigated using the data from the ENGELA study. ENGELA is a multicenter hospital-based casecontrol study that was carried out in France over the period September 2000 -December2004. In all, 822 cases (397 NHL, 149 LH, 168 SLP and 108 MM) and 752 controls were included and described 5481 and 5188 first degree relatives, respectively. A positive association with a familial history of hematopoietic cancer was observed for LN (OR = 1.7 [1.0-2.8]) overall and for LPS (OR = 3.2 [1.4-6.8]). The associations with HL (OR = 10.4 [2.0-53.8]) and NHL (OR = 2.4 [1.0-5.9]) were stronger
INTRODUCTION
Lymphoid neoplasm (LN), including Hodgkin's lymphoma (HL), non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and lymphoproliferative syndromes (LPS) are among the most common cancers in France after smoking-related cancers. According to data from French registries, there were approximately 17,000 new cases of LN in 2000 and almost 9,000 deaths 1 . In the last two decades , the yearly incidence rate for NHL has increased by more than 3% (3.8% for men and 3.5% for women), for reasons that have yet to be elucidated 1 .
A few risk factors for lymphoid neoplasms have been identified. They include congenital and acquired immunodeficiencies 2 -3 -4 -5 , chromosomal instability syndromes 6 -7 , Epstein-Barr Virus (EBV) infection 8 -9 -10 for some Burkitt's 11 - 10 and Hodgkin's lymphomas, Helicobacter pylori infection for gastric lymphoma 12 -13 and some autoimmune disorders for non-Hodgkin lymphoma 14 -15 - 16 -17 . Farming and exposure to pesticides 18 -19 -20 have also been consistently associated with LN.
Several studies have investigated the relationships between familial hematopoietic cancer aggregation and hematopoietic cancer and suggest a two-fold increase in the risk of NHL 21 -22 -23 - 24 , and HL 25 with a history of NHL in first degree relatives.
This study analyzed the association between LN and familial history of cancer in the first-degree relatives of the subjects included in a large case-control study designed to investigate for environmental and genetic risk factors for LN.
MATERIALS AND METHODS
The ENGELA study is a French multicenter hospital-based case-control study that was conducted in the main hospitals of Bordeaux, Brest, Caen, Nantes, Lille and Toulouse from September 2000 to December 2004 in order to investigate for environmental, infectious and genetics risk factors for LN.
The LN types considered in the study were LPS, which included chronic lymphoid leukaemia (CLL) and hairy cell leukaemia (HCL), NHL, HL and MM.
Cases and controls ascertainment
The eligible cases were subjects aged between 18 and 75 years old, recently diagnosed with LN, and residing in the catchment area of each hospital. The diagnosis of LN was documented by cytology and histology, and reviewed by a team of pathologists. All the cases were coded using the WHO classification (ICD-O-3). Cases with AIDS or treated with immunosuppressant drugs were not eligible. The inclusion of the cases took place within 6 months of diagnosis, except for LPS cases, who could be included up to 18 months post-diagnosis, in view of their good prognosis.
The controls were patients with no prior history of LN, recruited in the same hospital as the cases, mainly in orthopaedic and rheumatologic departments. The patients admitted for cancer or a disease directly related to occupation, smoking or alcohol consumption were not eligible as controls in order to avoid over-representation of some factors of interest. The controls were matched with cases by centre, age (± 3 years) and gender.
Out of the 872 eligible cases, 48 (5.5%) refused to participate. In addition, 2 cases who had been adopted were excluded from the analysis. Out of the 853 eligible controls, 100 refused the interview (11.7%) and one subject whose interview was incomplete was excluded a posteriori. 
Data collection
The data were collected in two stages. First, the cases and controls completed a standardized selfadministered questionnaire eliciting information on their socioeconomic characteristics, familial medical history and lifetime residential and occupational histories. The patients were asked to describe each of their first-degree relatives (gender, year of birth and, if applicable, year of death) and report each relative's history of cancer, leukemia or lymphoma, with details of cancer sites and years of occurrence. Each relative's age was considered to be that at the time of interview or death.
Each patient then underwent a face-to-face interview by a trained interviewer using a standardized questionnaire addressing personal medical history, lifestyle characteristics (smoking and alcohol, tea and coffee consumption), outdoor leisure activities and non-occupational exposure. The selfadministered questionnaire was also checked by the interviewer.
Blood samples were obtained from the cases and controls after consent form signature and biological specimens (constitutional DNA, tumor tissue) were placed on storage.
The blood samples and interviews were rendered anonymous.
Statistical analysis
Analyses were carried out for all LN taken together, for LN types LPS, NHL, HL and MM separately, and for the LPS (CLL and HCL) and NHL (DLCL and FL) subtypes.
The pair-matching used as a basis for the recruitment was broken in order to enable the whole control group to be used for the analysis of all LN. For each subgroup, the control group consisted in all controls that could be included in one of the age-gender-centre strata covered by the corresponding subgroup of cases.
Unconditional logistic regression was used to estimate the odds ratios (OR) and 95% confidence intervals (95% CI). The analyses were systematically adjusted for the stratification variables: age, centre and gender. Additional analyses including familial structure and socioeconomic category (blue collar, white collar, unemployed) in the models were also conducted.
The relatives' malignancies were considered overall (any cancer), by large group (solid cancer or hematopoietic cancer) and by disease site. The analysis also took into account the type of relative (parent, child, sibling), the age at onset of the earliest cancer in the family, the gender of the relatives with cancer, and the total number of relatives with cancer in the family.
Sensitivity analyses were also conducted to evaluate the robustness of the results. Each centre and each category of the controls' reasons for admission was excluded in turn. Additional analyses restricted to the matched samples were also carried out using conditional logistic regression models.
The SAS  software package (version 9, Cary, NC) was used for the analyses. All p values were twotailed.
RESULTS

Case and control comparability
The distribution of the 822 cases and 752 controls by the stratification variables, centre, age and gender, is shown in Table 1 . Significant differences between centre were observed, mainly because the Caen hospital had higher LPS recruitment than the others. The use of the whole control group assigned more than 2 controls to each case in most strata, except in the youngest categories, in which HL predominated. The MM cases differed from the controls with regard to gender since they did not show the male predominance observed in other lymphoid neoplasms. The cases of HL were more educated and had higher socioeconomic status than the controls ( Table 2 ). The cases and controls described 5481 (6.5 per subject on average) and 5188 (6.7 per subject on average) first degree relatives, respectively, and did not differ in terms of the number of relatives or the relatives' mean age. (Table 1 and Table 2 here)
Family history of cancer
Having at least one relative with a history of cancer was reported by 44.8% of the cases and 42.2% of the controls. None of the LN types was associated with a history of cancer in relatives (Table 3 ).
However, having had at least 2 relatives with cancer was associated with LPS.
In contrast, having at least one relative with a history of hematopoietic cancer was reported by 5.8% of the cases and 3.5% of the controls. A family history of hematopoietic cancer was significantly associated with LN overall (OR = 1.7 [1.0-2.8]), and with LPS in particular (OR = 3.2 [1.4-6.8] ). An elevated OR of 2.4 ([0.8-7.1]) was also observed for HL, but was not statistically significant. The association with LN and with LN subtypes was rather weak for the younger patients and stronger for the age group, 45-60 years.
The analyses stratified by gender showed that some associations were restricted to men. Among men, HL and NHL were significantly related to a familial history of hematopoietic cancer, with OR of 10.4 (Table 4 ), while no association was observed for women.
The associations were stronger when the relatives' disease had been diagnosed before the age of 45 years. The same pattern was observed for MM, although it was not significant, but not for LPS. Most frequently, the relatives' hematopoietic cancer had occurred at least 10 years before the diagnosis (cases) or interview (controls).
The associations between LPS subtypes, CLL and HCL, and a family history of hematopoietic cancer were close to those observed for the whole LPS group (Table 5 ). Similar associations were also observed for the FL and DLCL NHL subtypes.
More detailed information on the relatives' cancers showed that HL and NHL were only associated with a family history of lymphoma, while LPS was related to a history of lymphoma and leukemia ( (Table 6 ).
In order to investigate for potential familial anticipation, the 30 cases (12 LPS (11 CLL, 1 HCL), 9 NHL, 6 HL and 3 MM) who reported parents' hematopoietic cancer were considered separately. 
Additional adjustments and sensitivity analyses
The results were unchanged after adjustment for the number and age of the relatives, and for educational level and socioeconomic category. Conditional logistic regression models using the initial matching instead of age, gender and centre strata yielded similar results. The results did not change when each centre was excluded in turn or when the reason for admission of each group of controls was excluded in turn.
DISCUSSION
The present study showed that LN, and particularly LPS, was associated with a history of hematopoietic cancer in first-degree relatives. For HL and NHL, the associations seemed to be restricted to men, particularly when the hematopoietic cancer had occurred in relatives before the age of 45 years.
The inclusion of the cases was independent of their family history. The cases were recruited in main hospitals that were unlikely to attract specific patient categories. All eligible cases hospitalized in the department on the interviewers' working days were systematically contacted and the high participation rate (94.5%) made high self-selection on family history unlikely. In addition, the cases were included just after diagnosis to prevent survival bias that might have overrepresented cases with a family history in the event that the history was related, directly or indirectly, to a factor for a superior prognosis.
The cases and controls were hospitalized in the same center and resided in its catchment area. The controls were mainly recruited in orthopedic and rheumatologic departments, and were not to have been admitted for a disease directly related to smoking, alcohol intake or occupation, although they could have had those diseases in the past. Those precautions were taken to avoid artificial over-or under-representation of certain risk factors or socioeconomic categories that might be related to a family history of cancer or history reporting by the controls. In addition, the participation rate was quite high (88.3%), making self-selection on family history more improbable.
Over-or under-reporting was more possible in that the information was obtained by interview and not documented by medical reports. The cases were more conscious of their disease and perhaps more prone to having obtained information on their family history and relatives' cancer. However, the study focused on first-degree relatives (parents, siblings, children), whose medical history is less likely to be different for cases and controls. Moreover, the questionnaires were standardized and the cases and controls were interviewed under the same conditions in order to reduce the opportunity for differential misclassifications. Non-differential misclassifications were also reduced by those measures, but could not be completely prevented since it was not possible to access objective information (anonymous data). The misclassifications are probably stronger for specific types of cancer than for broad categories. In addition, some LH or NHL diagnoses in relatives may have been confused: cases may have been influenced by their own diagnosis when they reported a history of lymphoma in their relatives Several studies have quantified misclassifications by comparing the reported family history of cancer with the relatives' medical files. Strong concordances were observed for cancer in first-degree relatives 26 -27 -28 -29 -30 -31 . Differences were observed for some cancer sites 26 -28 -32 -30 -31 -32 . The greatest differences were reported for hepatic, uterine and cervical disease sites 26 -27 -33 - 31 .
The reporting of cancer in offspring and, to a lesser extent, siblings was hampered by censoring by age. This probably reduced the power of the study, particularly for HL. The power was also weak for women and for multiple myeloma, due to small numbers.
Socioeconomic category is a strong potential confounder since it is usually related to the risk of smoking-related cancer in the family and to the quality of the report, assumed to be more accurate in more educated subjects. However, analyses were adjusted for socioeconomic category and the results were very similar.
The Epilymph study 34 also showed a significant and positive association between lymphoid neoplasm taken as a whole and a history of hematopoietic cancer in first degree relatives. Several studies have shown specific associations between a familial history of hematopoietic cancer and LPS 35 -34 -36 -37 -38 , NHL 34 -39 -33 -40 , and HL 41 . However, in the present study, the latter two relationships were not significant when both genders were considered together. The OR were higher for men, which has also been observed in two other studies 25 -33 . The associations were not only stronger in males, but they were also mostly due to hematopoietic cancers in male relatives. These results suggest a sex-linked genetic susceptibility to hematopoietic cancers. Stronger associations between hematopoietic cancer in male relatives were also reported for HL and NHL in a study in the US 22 and for CLL in the Swedish Family-Cancer Database 37 .
Two studies on MM showed associations with parental history of MM 21 -42 . The present study did not evidence any such association. HL and NHL were mainly associated with lymphomas in relatives, which supports the results of previous studies 21 -34 -41 -37 -25 -23 -39 - 33 .
Anticipation of CLL diagnosis in CLL case families, which implies that CLL presents earlier than in the preceding generation, has been suggested in a few studies 37 -43 -44 -45 but not that of the Swedish Family-Cancer Database 37 -46 . The finding in the present study, based on 6 CLL-CLL parent-case pairs is compatible with anticipation. The cases were more conscious of their disease and perhaps more prone to having obtained information on their family history and relatives' cancer, which may induce a recall bias. However, the study focused on first-degree relatives (parents, siblings, children), whose medical history is less likely to be differentially reported for cases and controls. Daugherty et al (2005) 46 , using data from the Swedish Family-Cancer Database and the Danish registry, showed that the secular trends in incidence and diagnosis of NHL could give rise to apparent anticipation. They did not evidence any anticipation of HL, CLL and MM cases. . Secular trends and censoring of the youngest parents may result in false anticipation. Moreover, in CLL, anticipation was assumed to be due to an increase in genomic instability over succeeding generations, but studies of nucleotides repeats did not support that hypothesis ( Auer et al, 2001) 47 .
The study showed associations between both NHL and HL and a family history of kidney and digestive tract cancers, between LPS and a family history of breast cancer, and between MM and a family history of melanoma. The analysis was not hypothesis-driven. The numbers were small and resulted in wide confidence intervals. Multiple tests increased the risk that an association may have occurred by chance. Therefore, the results are to be considered exploratory. A few studies have reported associations between LN and solid tumors, but no clear consistency has emerged.
Associations between NHL and kidney cancer 33 or colorectal cancers 41 -38 , and between breast cancer and LPS 38 have been reported and are in line with the results of the present study. In contrast, to the authors' knowledge, the association between MM and a family history of melanoma has never been reported.
The study also showed a slight trend toward cases reporting hematopoietic cancer in the spouse more frequently than controls. Spouses may be assumed to be aware of each other's health; recall bias is thus rather unlikely. However, the numbers are small and the trend may be a chance finding. Out of the three studies that investigated cancer among spouses 48 -49 -50 , a Japanese study 50 showed an increase in all malignant neoplasm in spouses and an American study 48 showed an increase in NHL.
As they stand, the results of the present study do not strongly support an increase in hematopoietic cancer in spouses similar to that in first degree relatives. Nonetheless, it is still possible that a part of familial aggregation results from an environmental exposure -possibly to an infectious agent -shared by the family. However, the predominance of the association with a history of hematopoietic cancer in men, particularly for HL, suggests a sex-linked genetic predisposition.
CONCLUSION
In conclusion, the results mainly support the involvement of genetic factors in the aetiology of NHL, and suggest that at least some of those factors could be sex-linked. However, the slight overrepresentation of affected spouses among the cases may also support the responsibility of environmental factors. 
